Toward Intracellular Targeted Delivery of Cancer Therapeutics
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Link
http://link.springer.com/content/pdf/10.1007/BF03261882.pdf
Reference90 articles.
1. Wick W, Weller M, Weiler M, et al. Pathway inhibition: emerging molecular targets for treating glioblastoma. Neuro Oncol 2011 Jun; 13(6): 566–79
2. Weiner LM, Dhodapkar MV, Ferrone S. Monoclonal antibodies for cancer immunotherapy. Lancet 2009 Mar; 373(9668): 1033–40
3. Stupp R, Dietrich PY, Ostermann KS, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002 Mar; 20(5): 1375–82
4. Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade III and IV: confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival times-a prospective multicenter trial of the Scandinavian Glioblastoma study Group. Cancer 1981 Feb; 47(4): 649–52
5. Stern JI, Raizer JJ. Chemotherapy in the treatment of malignant gliomas. Expert Rev Anticancer Ther 2006 May; 6(5): 755–67
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of stimulatory responsive soft nanoparticles for intracellular drug delivery;Nano Research;2023-01-14
2. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach;Bioorganic Chemistry;2021-07
3. Interaction of a Triantennary Quinoline Glycoconjugate with the Asialoglycoprotein Receptor;ChemMedChem;2021-05-05
4. In Vitro Selective Suppression of Tumor Cells by an Oncolytic Peptide in Pancreatic Ductal Adenocarcinoma;International Journal of Peptide Research and Therapeutics;2020-11-06
5. ChAcNLS, a Novel Modification to Antibody-Conjugates Permitting Target Cell-Specific Endosomal Escape, Localization to the Nucleus, and Enhanced Total Intracellular Accumulation;Molecular Pharmaceutics;2016-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3